-
EP3233862
European procedure
Extract from the Register of European Patents
EP About this file: EP3233862
| EP3233862 - IMIDAZOPYRIDAZINE DERIVATIVES AS PI3KBETA INHIBITORS [Right-click to bookmark this link] | |||
| Former [2017/43] | IMIDAZOPYRIDAZINE DERIVATIVES AS 3 INHIBITORS | ||
| [2018/08] | Status | No opposition filed within time limit Status updated on 03.07.2020 Database last updated on 06.07.2024 | |
| Former | The patent has been granted Status updated on 31.05.2019 | ||
| Former | Grant of patent is intended Status updated on 06.02.2019 | ||
| Former | Request for examination was made Status updated on 29.01.2019 | ||
| Former | Grant of patent is intended Status updated on 27.01.2019 | ||
| Former | Request for examination was made Status updated on 15.12.2018 | ||
| Former | Grant of patent is intended Status updated on 03.09.2018 | ||
| Former | Request for examination was made Status updated on 22.09.2017 | ||
| Former | The international publication has been made Status updated on 15.06.2017 | Most recent event Tooltip | 03.07.2020 | No opposition filed within time limit | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2019/05] |
| Former [2017/43] | For all designated states Janssen Pharmaceutica, N.V. Turnhoutseweg 30 2340 Beerse / BE | Inventor(s) | 01 /
MEVELLEC, Laurence, Anne Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 02 /
MEERPOEL, Lieven Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | 03 /
COUPA, Sophie Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 04 /
PONCELET, Virginie, Sophie Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 05 /
PILATTE, Isabelle, Noëlle, Constance Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 06 /
PASQUIER, Elisabeth, Thérèse, Jeanne Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 07 /
BERTHELOT, Didier, Jean-Claude Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 08 /
QUEROLLE, Olivier, Alexis, Georges Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 09 /
MEYER, Christophe Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 10 /
ANGIBAUD, Patrick, René Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 11 /
DEMESTRE, Christophe, Gabriel, Marcel Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | 12 /
MERCEY, Guillaume, Jean, Maurice Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003 92787 Issy-les Moulineaux Cedex 9 / FR | [2017/43] | Representative(s) | Lenaerts, Philip Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [2017/43] | Application number, filing date | 15810784.7 | 18.12.2015 | [2017/43] | WO2015EP80604 | Priority number, date | EP20140199322 | 19.12.2014 Original published format: EP 14199322 | [2017/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016097347 | Date: | 23.06.2016 | Language: | EN | [2016/25] | Type: | A1 Application with search report | No.: | EP3233862 | Date: | 25.10.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.06.2016 takes the place of the publication of the European patent application. | [2017/43] | Type: | B1 Patent specification | No.: | EP3233862 | Date: | 03.07.2019 | Language: | EN | [2019/27] | Search report(s) | International search report - published on: | EP | 23.06.2016 | Classification | IPC: | C07D487/04, A61K31/5025, A61P35/00 | [2017/43] | CPC: |
C07D487/04 (EP,CN,IL,KR,US);
A61K31/5025 (IL,KR);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P15/08 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
C07D519/00 (EP,CN,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/43] | Extension states | BA | 19.07.2017 | ME | 19.07.2017 | Validation states | MA | 19.07.2017 | MD | 19.07.2017 | Title | German: | IMIDAZOPYRIDAZINDERIVATE ALS PI3KSS INHIBITOREN | [2018/33] | English: | IMIDAZOPYRIDAZINE DERIVATIVES AS PI3KBETA INHIBITORS | [2018/33] | French: | DÉRIVÉS D'IMIDAZOPYRIDAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3KBETA | [2018/33] |
| Former [2017/43] | IMIDAZOPYRIDAZINDERIVATE ALS 3-INHIBITOREN | ||
| Former [2017/43] | IMIDAZOPYRIDAZINE DERIVATIVES AS 3 INHIBITORS | ||
| Former [2017/43] | DÉRIVÉS D'IMIDAZOPYRIDAZINE UTILISÉS EN TANT QU'INHIBITEURS DE P 3 | Entry into regional phase | 19.07.2017 | National basic fee paid | 19.07.2017 | Designation fee(s) paid | 19.07.2017 | Examination fee paid | Examination procedure | 13.06.2017 | Date on which the examining division has become responsible | 19.07.2017 | Examination requested [2017/43] | 04.09.2018 | Communication of intention to grant the patent | 13.12.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 07.02.2019 | Communication of intention to grant the patent | 22.05.2019 | Fee for grant paid | 22.05.2019 | Fee for publishing/printing paid | 22.05.2019 | Receipt of the translation of the claim(s) | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/32] | Fees paid | Renewal fee | 02.01.2018 | Renewal fee patent year 03 | 02.01.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2008138834 (NOVARTIS AG [CH], et al) [A] 1-15* example -; claim - *; | [A]WO2010007099 (CELLZOME LTD [GB], et al) [A] 1-15 * example -; claim - *; | [A]WO2011047770 (MERCK PATENT GMBH [DE], et al) [A] 1-15 * example -; claim - * | by applicant | WO2007038314 | WO2008008539 | WO2008014219 | WO2008030579 | WO2008138834 | WO2009060197 | WO2009091374 | WO2010007099 | WO2011022439 | WO2011047770 | WO2011058109 | WO2011123751 | WO2012047538 | WO2012116237 | WO2013028263 | US2013157977 | WO2013095761 | WO2014078211 | - K.D COURTNEY; R.B. CORCORAN; J.A. ENGELMAN, JOURNAL OF CLINICAL ONCOLOGY., (2010), vol. 28, page 1075 | - B. VANHAESEBROECK; M.D. WATERFIELD, EXPERIMENTAL CELL RESEARCH.,, (1999), vol. 253, pages 239 - 254 | - K.D COURTNEY, R.B. CORCORAN AND J.A. ENGELMAN, JOURNAL OF CLINICAL ONCOLOGY, (2010), vol. 28, page 1075 | - K.D COURTNEY; R.B. CORCORAN; J.A. ENGELMAN, JOURNAL OF CLINICAL ONCOLOGY, (2010), vol. 28, page 1075 | - ZHAO L.; VOGT P. K., ONCOGENE, (2008), vol. 27, pages 5486 - 5496 | - MYERS M. P; PASS I; BATTY I. H; VAN DER KAAY J; STOLAROV J. P; HEMMINGS B. A; WIGLER M. H; DOWNES C. P; TONKS N. K, PROC. NATL.ACAD. SCI, (1998), vol. 95, pages 13513 - 13518 | - SCIENCE, (1997), vol. 277, pages 567 - 570 | - D. R. CALNAN; A. BRUNET, ONCOGENE, (2008), vol. 27, page 2276 | - JIA S; LIU Z; ZHANG S; LIU P; ZHANG L; LEE SH; ZHANG J; SIGNORETTI S; LODA M; ROBERTS TM, NATURE, (2008), vol. 454, pages 776 - 9 | - WEE S; WIEDERSCHAIN D; MAIRA SM; LOO A; MILLER C; DEBEAUMONT R; STEGMEIER F; YAO YM; LENGAUER C, PROC. NATL. ACAD. SCI (USA), (2008), vol. 105, page 13057 | - S. P. JACKSO ET AL., NATURE MEDICINE, (2005), vol. 11, pages 507 - 514 | - MARQUES RB ET AL., "High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models", EUR UROL, (2014), URL: http://dx.doi.org/10.1016/j.eururo.2014.08.053 |